An ABA practice risk and control review examines current risks, incidents, complaints, payer and regulatory changes, control performance, overrides, exceptions, audit findings, corrective actions, and residual exposure. It decides where to contain, accept within authority, reduce, transfer consequences, stop work, add resources, or retest. A policy, insurance policy, or completed checklist does not prove that a control operated or that remaining risk is acceptable.

Define the risk and control review

Theo organizes the review by risk and affected service rather than department. One issue can involve clinical, workforce, payer, privacy, security, finance, facility, and vendor owners without merging their authority. The review has a charter, purpose, evidence cutoff, eligible cohort, source definitions, qualified participants, decision agenda, action record, escalation route, validation method, and next review.

Build the risk-review fields

Theo records review date and scope, risk and source event, affected clients, staff, sites and systems, inherent consequence and likelihood method, current controls, population and performance evidence, exception and override, incident and complaint links, source change, finding, immediate safeguard, control owner, test and result, residual exposure, treatment option, decision owner and authority, resource, corrective action, target, interim monitoring, retest, recurrence, escalation, acceptance expiration, and closure.

Turn discussion into attributable decisions

Theo starts with new high-consequence events, failed controls, overdue corrective actions, and changed sources. Risk scores help order attention but never replace facts or professional judgment. A residual-risk acceptance identifies the scope, basis, authority, safeguards, duration, and review trigger. Insurance or contractual allocation may change financial consequences without reducing operational likelihood or harm. When the review changes a clinical, payer, workforce, privacy, security, or legal control, the authorized domain owner approves the change and validates it in the affected workflow.

Build a decision-grade evidence pack

The risk pack shows the current population, control performance, exceptions, incidents, complaints, audit results, and open actions. Theo avoids averaging high-consequence failures into a reassuring rate. He distinguishes design, implementation, operating, and outcome evidence. Corrective actions include completion proof and a fresh retest. Repeated findings link to their shared cause and decision history. Closed risks remain searchable with the accepted disposition and triggering conditions. Emerging risks can stay provisional while named owners gather evidence and protect clients or staff.

Prepare the risk review before the meeting

Theo asks risk and control owners to update evidence before the review rather than debate old ratings during it. Incident, complaint, audit, source-change, exception, and override records feed the agenda. Testers disclose conflicts and show the eligible population. Qualified clinical, privacy, security, payer, workforce, finance, facility, and legal owners prepare their conclusions separately. The meeting chooses a response, resources it, and sets a retest. Urgent safeguards begin earlier and remain visible until normal controls validate.

Protect urgent routes and qualified authority

Theo never delays emergency, safety, mandated, privacy, clinical, payroll, or payer-clock action until the next meeting. Case-specific clinical decisions stay with qualified clinicians. Employment, accommodation, payer, finance, privacy, security, facility, and legal decisions stay with their authorized roles. The review records the conclusion and linked source while restricting sensitive detail to approved systems.

Keep cohorts, clocks, and exceptions honest

Theo defines the event, eligible population, numerator, denominator, maturity window, exclusions, missing data, source date, and workflow version before reporting a measure. Pending, held, rejected, withdrawn, invalid, and incomplete items remain visible. Counts accompany percentages. Average time appears with range, oldest items, and start and end events. A changed definition creates a new series or a documented restatement.

Work through a fictional risk review

Theo reviews 25 material risk-control topics. Eighteen have current sources, evidence, owners, safeguards, decisions, and retest plans. Two use stale populations, one hides an override, one has no acceptance authority, one lacks a client safeguard, and two close actions without retesting. Five repair. Two remain open. The scenario is synthetic. It tests evidence, authority, decision, follow-through, and denominator logic without establishing clinical quality, legal compliance, payer approval, staffing, safety, client satisfaction, financial accuracy, or outcome.

Calculate the review measures honestly

Initial review integrity is 18 of 25, or 72.0%. Twenty-three topics validate, or 92.0%. Risks, controls, performances, exceptions, incidents, findings, actions, and retests remain separate.

Address the main risk-control weakness

Risk meetings can become static heat-map reviews. Theo centers changed evidence, decisions, actions, and validation instead of color labels.

Test the risk review against hard cases

Theo tests new regulation, payer change, clinical incident, staff concern, privacy event, security issue, facility hazard, vendor failure, control override, accepted risk, failed retest, and recurring issue. Each case states the source, qualified owner, affected cohort, immediate safeguard, decision, conditions, action, evidence, validation, and next review.

Close with unresolved risk work visible

Theo confirms charter, source currency, cohort, authority, qualified participation, direct input, decisions, dissent, safeguards, actions, due dates, downstream updates, validation, recurring conditions, and open work. The risk and control review remains draft until every named reviewer completes the required review.

Place the risk review within organizational scope

Theo uses the CASP Organizational Guidelines public overview for high-level business, clinical-operations, and risk-management context. CASP sells the detailed guidance. The public page does not prescribe this risk and control review, validate the evidence pack, or authorize conclusions about material exposure, operating evidence, and corrective action.

Use compliance guidance within the review's limits

Theo treats the OIG General Compliance Program Guidance as voluntary and nonbinding. Its discussions of leadership, risk assessment, reporting, auditing, corrective action, incentives, and oversight inform review design. Current law, payer, professional, workforce, privacy, finance, safety, facility, contract, and legal sources control the decisions.

Use broad business orientation carefully

Theo uses the SBA Manage Your Business guide only as broad orientation across finances, employees, compliance, marketing, emergencies, and closure. It gives no ABA clinical, payer, privacy, safety, tax, facility, or legal authority. The evidence pack cites current primary sources for material conclusions.

Preserve professional accountability in the meeting

Theo applies the current BACB Ethics Code to covered people and professional activities. It addresses competence, responsibility, client involvement, documentation, supervision, risk, evaluation, billing, and reporting. BACB has no separate corporate jurisdiction. Review forums request and record qualified clinical decisions without transferring them to owners or software.

Include leadership and workforce voice

Theo uses OSHA's management leadership and worker participation pages as general safety-program guidance on goals, resources, accountability, reporting, participation, response, and nonretaliation. The pages do not create a universal ABA review method. Staff need usable routes to raise workload, access, safety, and implementation evidence.

Limit sensitive data and payer inferences

Theo applies HHS minimum-necessary guidance to role-based PHI access when the standard covers the use, disclosure, or request. Restricted clinical, personnel, legal, and security detail stays in approved records. The HealthCare.gov preauthorization glossary states that preauthorization is not a promise the plan will cover the cost. Authorization, claim acceptance, adjudication, payment, and client responsibility remain distinct.

Related resources

Sources